BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

12 articles for F Pierre

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Potential use of selective and nonselective Pim kinase inhibitors for cancer therapy.EBI
Cylene Pharmaceuticals
Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor.EBI
TBA
Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells.EBI
Cylene Pharmaceuticals
7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activity.EBI
Cylene Pharmaceuticals
Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer.EBI
Cylene Pharmaceuticals
Synthesis and SAR of inhibitors of protein kinase CK2: novel tricyclic quinoline analogs.EBI
Cylene Pharmaceuticals
Peptidomimetics for the treatment of Norovirus infectionBDB
Emory University
Pyrimidinone derivatives as SHP2 antagonistsBDB
Merck Patent
Compounds having CRTH2 antagonist activityBDB
Atopix Therapeutics
Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain.BDB
Hospital Saint-Antoine
Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 5: Combined A- and C-ring structure-activity relationship studies.BDB
Eli Lilly